|P wave duration and dispersion in patients with hyperthyroidism and the short-term effects of antithyroid treatment.|
|Jump to Full Text|
|PMID: 19763193 Owner: NLM Status: PubMed-not-MEDLINE|
|BACKGROUND: Prolonged P wave duration and P wave dispersion (PWD) have been associated with an increased risk for atrial fibrillation (AF). Hyperthytodism is a frequent cause of atrial fibrillation (AF).
METHODS: Forty-two patients with newly diagnosed overt hyperthyroidism and 20 healthy people were enrolled in the study. Transthoracic echocardiography, 12 lead surface ECG and thyroid hormone levels were studied at the time of enrollment and after achievement of euthyroid state with propylthiouracil treatment.
RESULTS: Maximum P wave duration (Pmax) (97.4+/-14.6 vs. 84.2+/-9.5 msec, p<0.001), PWD (42.9+/-10.7 vs. 31.0+/-6.2 msec, p<0.001), deceleration (DT) (190.7+/-22.6 vs. 177.0+/-10.2 msec, p=0.013) and isovolumetric relaxation times (IVRT) (90.9+/-11.2 vs. 79.6+/-10.5 msec, p<0.001) were significantly higher in hyperthyroid patients compared to control group. Pmax and PWD were significantly correlated with the presence of hyperthyroidism. Pmax (97.4+/-14.6 to 84.3+/-8.6 msec, p<0,001) Pmin (54.1+/-8.6 to 48.1+/-8.5 msec, p=0.002), PWD (42.9+/-10.7 to 35.9+/-8.1 msec, p=0.002) and DT (190.7+/-22.6 to 185.5+/-18.3, p=0.036) were significantly decreased after achievement of euthyroid state in patients with hyperthyroidism. Diastolic dyfunction was seen in 5 patients at hyperthroid state but only in one patient at euthyroid state.
CONCLUSIONS: Hyperthyroidism is associated with prolonged P wave duration and dispersion. Achievement of euthyroid state with propylthiouracil treatment results in shortening of P wave variables. Diastolic function may have a partial effect for the increased Pmax and PWD. Shortening of Pmax and PWD may be a marker for the prevention of AF with the anti-thyroid treatment.
|Unal Guntekin; Yilmaz Gunes; Hakki Simsek; Mustafa Tuncer; Sevket Arslan|
Related Documents :
|9177413 - Changes in epitopes for thyroid-stimulating antibodies in graves' disease sera during t...
59733 - Pituitary-thyroid regulation in euthyroid patients with graves' disease previously trea...
23625683 - Normalized transcranial doppler velocities, stroke prevention and improved pulmonary fu...
|Type: Journal Article Date: 2009-09-01|
|Title: Indian pacing and electrophysiology journal Volume: 9 ISSN: 0972-6292 ISO Abbreviation: Indian Pacing Electrophysiol J Publication Date: 2009|
|Created Date: 2009-09-18 Completed Date: 2010-05-20 Revised Date: 2013-05-23|
Medline Journal Info:
|Nlm Unique ID: 101157207 Medline TA: Indian Pacing Electrophysiol J Country: India|
|Languages: eng Pagination: 251-9 Citation Subset: -|
|YuzuncuYil University, Faculty of Medicine, Cardiology Department, Van, Turkey. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Indian Pacing Electrophysiol J
Journal ID (publisher-id): Indian Pacing Electrophysiol J
Publisher: Indian Heart Rhythm Society
Copyright: ? 2009 Guntekin et al.
collection publication date: Season: Sep?Oct Year: 2009
Electronic publication date: Day: 01 Month: 9 Year: 2009
Volume: 9 Issue: 5
First Page: 251 Last Page: 259
PubMed Id: 19763193
Publisher Id: ipej090251-00
|P Wave Duration And Dispersion In Patients With Hyperthyroidism And The Short-term Effects Of Antithyroid Treatment|
|Unal Guntekin, MD1|
|Yilmaz Gunes, MD1|
|Hakki Simsek, MD1|
|Mustafa Tuncer, MD1|
|Sevket Arslan, MD2|
1YuzuncuYil University, Faculty of Medicine, Cardiology Department, Van, Turkey
2Yuzuncu Yil University, Faculty of Medicine, Internal Medicine Department, Van, Turkey
|Correspondence: Address for correspondence: Hakki Simsek, Yuzuncu Yil University, Faculty of Medicine, Cardiology Department, Van, Turkey. E-mail: firstname.lastname@example.org
Hyperthyroidism has profound effects on the heart, including increased heart rate, slightly enhanced systolic function, left ventricular (LV) hypertrophy, and diastolic dysfunction [1-9]. Atrial fibrillation (AF) is the most common cardiac dysrhythmia in the adult population. Hyperthyroidism is a major cause of paroxysmal and latent atrial fibrillation (AF) [10-12] and AF, after the sinus tachycardia, is the second common dysrhythmia in patients with hyperthyroidism. Approximately in 10 - 15 % of hyperthyroid patients AF develop .
P-wave duration and P-wave dispersion (PWD) are electrocardiographic (ECG) signs of prolongation of intraatrial and interatrial conduction time and inhomogeneous propagation of sinus impulses that are well known electrophysiological characteristics of the atrium prone to fibrillate [14-17].
In the present study, we aimed to evaluate P wave variables and LV diastolic function in hyperthyroid patients and to search the effects of shortterm propyl thio uracil (PTU) treatment.
Forty two consecutive hyperthyroid patients followed at out patient clinic of the endocrinology and metabolism department of the hospital and 20 healthy euthyroid healthy voluntary people were evaluated with 12-lead ECG and transthoracic echocardiography. Patients with systemic hypertension, diabetes mellitus, history of structural or ischemic heart disease, chronic obstructive pulmonary disease or any associated systemic disease and patients using systemic drugs, like steroids, antiarrythmics or antipsychotics, were excluded. The study was approved by the Yuzuncu Yil University, Faculty of Medicine Ethics Committee in accordance with the Declaration of Helsinki. All participants were informed about the study and their consents were obtained.
In the patient group ECG and echocardiographic examinations were performed before treatment and after achievement of euthyroid state with PTU treatment.
The evaluation of thyroid morphology and function was performed by clinical examination, assessment of serum free thyroid hormone T3 and T4 (FT3 and FT4) and throid stimulating hormone (TSH) levels, and ultrasound examination of the thyroid gland. A total of 5 ml of venous blood samples were drawn and then centrifuged at 2000 rpm for 10 min in a refrigerated centrifuge to separate serum. Serum FT3, FT4, TSH, levels were measured using the commercial Immulite kits, which are solid-phase, two-site chemiluminescent immunumetric assay in Immulite autoanalyser (IMMULITE, DPC, USA). The normal reference intervals were 0.80 - 1.80 ng / dl, 1.8 - 4.2 pg/ ml and 0.40 - 4.0 mIU / ml for FT4, FT3 and TSH respectively.
The echocardiographic examination was performed at rest, with the patient at left lateral decubitis position, using a commercially available echocardiographic device (Vivid 3, General Electric) with a 3 MHz transducer, by two experienced echocardiographers who were blinded to the clinical data. Using M-mode echocardiography, long-axis measurements were obtained at the level distal to the mitral valve leaflets according to current recommendations of the American Society of Echocardiography . The pulsed Doppler sampling volume was placed between the tips of the mitral valve leaflets to obtain maximum filling velocities. Early diastolic flow (E), atrial contraction signal (A), E/A ratio and E deceleration time (DT) were measured. Isovolumetric relaxation time (IVRT) was determined as the interval between the end of the aortic outflow and the start of the mitral inflow signal.
Tissue Doppler imaging (TDI) was acquired to assess diastolic function. The pulsed wave spectral mode was used for TDI. Filters and baselines were corrected when the velocity ranged between -20 and 20 cm/s. From the apical 4-chamber view, a 5-mm sample volume was placed at the lateral corner of the mitral annulus. Early (Em) and late (Am) diastolic velocities were obtained. All values were measured on three separate beats and then averaged for all parameters.
Impaired left ventricular relaxation was defined as having an E/A ratio of <1 (< 0.5 for >50 years), DT > 200 msec and IVRT > 100 msec (>105 msec for >50 years), all together and/or E/Em ratio of >10 and Ea < 10 cm/sec in the presence of a preserved ejection fraction .
Twelve-lead ECGs were obtained at rest, with 20 mm/mV amplitude and 50 mm/sec rate with standard lead positions. ECGs were manually measured by the use of a magnifying glass by two blinded cardiologists having no information about the patients. The beginning of the P wave was defined as the point where the initial deflection of the P wave crossed the isoelectric line, and the end of the P wave was defined as the point where the final deflection of the P wave crossed the isoelectric line. The difference between maximum and minimum P wave duration was defined as PWD (Figure 1).
Intra-observer and inter-observer coefficients of variation for echocardiographic parameters and P wave variables were found to be less than 5% and nonsignificant.
Data were presented as mean ? standard deviation (SD). Using an SPSS package 10.0 (SPSS Inc., Chicago, Illionis, USA) the changes of parameters after treatment were compared with paired t-tests. Differences in mean values between groups were assessed using the Student t test and with Mann-Whitney's U-test for variables without normal distribution. Pearson correlation analysis was used to assess the correlation between variables. A two-tailed p value < 0.05 was considered significant.
Maximum P wave duration, PWD, DT and IVRT were significantly higher in hyperthyroid patients compared to control group (Table 1). PWD was significantly correlated with presence of hyperthyroidism (r=0.501, p<0.001), IVRT (r=0.390, p=0.002), E/A (r=-0.350, p=0.005), DT (r=0.327, p=0.010), presence of diastolic dysfunction (r=0.298, 0.019) and age (r=0.255, p=0.045). Pmax was also significantly correlated with hyperthyroidism (r=0.404, p=0.001), age (r=0.270, p=0.034), E/A (r=-0.313, p=0.013), diastolic dysfunction (r=0.268, p=0.035), IVRT (r=0.265, p=0.038) and DT (r=0.259, p=0.042).
Euthyroid state was achieved during a 2,5?0,8 months. Pmax, Pmin, PWD and DT were significantly decreased after achievement of euthyroid state in patients with hyperthyroidism (Table 2, Figure 2). The slight decrease in IVRT was not significant. Diastolic dyfunction was observed in 5 patients at hyperthroid state but only in one patient at euthyroid state.
In this study we found that P maximum and PWD values were increased in hyperthyroidism and treatment with PTU results in improvement in Pmax, PWD and LV diastolic function parameters.
The correlation between the presence of intraatrial conduction abnormalities and the induction of paroxysmal AF has been well documented [15-20]. P-wave dispersion has been advocated as a novel measurement of the heterogeneity of atrial depolarizations . The increase in dispersion of atrial refractoriness may favor a re-entry mechanism leading to AF because fragmentation of the depolarizing wave front may occur when it faces adjoining atrium with nonuniform refractoriness [21,22]. Accordingly, prolonged P-wave duration and increased PWD have been reported to carry an increased risk for AF [14,15].
Frequency of AF is increased in hyperthyroidism . The cardiovascular effects of hyperthyroidism result from the increased metabolic demands of the body tissues and from the direct chronotropic and inotropic effects of excess thyroid hormone on the heart. Thyroid hormone alters the action potential duration and the speed of repolarization of atrial and ventricular myocytes [23,24]. Thyroid hormone administration shortens action potential duration and decreases the refractoriness of cardiomyocytes facilitating the maintenance of multiple reentrant circuits in hearts .
Increase in Pmax and PWD values have been reported in hyperthyoidism . Direct effects of thyroid hormones on ionic channels and action potential [23-25] and increased sympathetic activity [27,28] may be responsible fort this finding. Recent studies established the presence of prolonged P wave duration and P dispersion as markers of increased risk of AF in hyperthyroid subjects [14,16,29]. Treatment of hyperthyroidism is frequently associated with reversion to sinus rhythm. A recent study showed that reversion to sinus rhythm occurred in 62 percent of 163 patients within 8-10 weeks after they returned to a euthyroid state . Katircibasi et al  demonstrated that the prolonged P wave duration and dispersion recovered with PTU treatment at levels measured in healthy control subjects. Our results supports these findings. Therefore, anti-thyroid treatment may have preventive effects in the development of AF in patients with hyperthyroidism.
Impaired left ventricular relaxation has been reported to effect PWD . It has been reported that hyperthyrodism has profound effects on cardiac diastolic function that are at least in part reversible after restoration of euthyroidism [8,32,35]. In the present study, diastolic function parameters of DT and IVRT were increased in hyperthyroid state. In addition, diastolic function was normalized in 4 of 5 patients after achievement in euthyroid state. There were significant correlations between diastolic function and Pmax and PWD. Therefore, improvement in PWD in our study may be partially explained by improvement in diastolic function.
Small number of study patients and short-term follow-up are the major limitations. Another important limitation of our study is manual calculation of P-wave parameters using magnifying lens instead of computer-assisted P-wave calculations. We do not have automated measurement facilities for PWD. However, thermal, digital, and signal-averaging ECG systems have been used to evaluate PWD which was measured manually either on paper or on a high-resolution computer screen. Although, several studies have demonstrated a low error of the measurement of P wave dispersion on paper printed ECGs [28,7] others suggested that manual PWD measurement on paper printed ECGs obtained at a standard signal size and paper speed may have a questionable accuracy and reproducibility .
Hyperthyroidism is associated with prolonged P wave duration and dispersion. Achievement of euthyroid state with PTU treatment results in shortening of P wave variables. Diastolic function may have a partial effect for the increased Pmax and PWD. However, there is need for larger prospective studies to elucidate the role of P wave disturbances in prediction and early treatment of AF in hyperthyroid patients.
|Kahaly GJ,et al. Thyroid hormone action in the heartEndocr RevYear: 20052670415632316|
|Klein I,et al. Thyrotoxicosis and the heartEndocrinol Metab Clin North AmYear: 199827519534027|
|Forfar JC,et al. Occult thyrotoxicosis: a reversible cause of idiopathic atrial fibrillationAm J CardiolYear: 1979449110126|
|Gilligan DM,et al. The management of atrial fi brillationAm J MedYear: 19961014138873513|
|Sawin CT,et al. Low serum thyrotropin concentrations as a risk factor for atrial fi brillation in older personsN Engl J MedYear: 199433112497935681|
|Dilaveris PE,et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillationAm Heart JYear: 19981357339588401|
|Aytemir K,et al. P-wave dispersion on 12-lead electrocardiogram in patients with paroxysmal atrial fibrillationPacing Clin ElectrophysiolYear: 200023110910914366|
|Steinberg JS,et al. Value of P wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgeryCirculationYear: 19938826188252672|
|Dilaveris PE,et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillationPacing Clin ElectrophysiolYear: 20002335210750136|
|Klein I. Thyroid hormone and the cardiovascular systemAm J MedYear: 1990886312189307|
|Forfar JC,et al. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathyN Engl J MedYear: 198230711657121544|
|Polikar R,et al. The thyroid and the heartCirculation Year: 19938714358490997|
|Ching GW,et al. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosisHeartYear: 1996753638705762|
|Fazio S,et al. Effects of thyroid hormone on the cardiovascular systemRecent Prog Horm ResYear: 2004593114749496|
|Biondi B,et al. Effects of subclinical thyroid dysfunction on the heartAnn Intern MedYear: 200213790412458990|
|Biondi B,et al. Subclinical hypothyroidism and cardiac functionThyroidYear: 20021250512165114|
|Biondi B,et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middleaged patientsJ Clin Endocrinol MetabYear: 200085470111134131|
|Lang RM,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of CardiologyJ Am Soc EchocardiographyYear: 2005181440|
|Nagueh SF,et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressuresJ Am Coll CardiolYear: 19973015279362412|
|Buxton AE,et al. Atrial conduction: effects of extrastimuli with and without atrial dysrhythmiasAm J CardiolYear: 1984547556486024|
|Roithinger FX,et al. The spatial dispersion of atrial refractoriness and atrial fibrillation vulnerabilityJ Interv Card ElectrophysiolYear: 1999331110525245|
|Michelucci A,et al. P wave assessment: Statement of the art updateCard Electrophys RevYear: 20026215|
|Sun ZQ,et al. Effects of thyroid hormone on action patetial and repolarizing currents in rat ventricular myocytesAm J PhysiolYear: 2000278302|
|Johnson PN,et al. Action of thyroid hormone on the transmembran potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbitsCardiologyYear: 1973582734792097|
|Han J,et al. Effects of thyroid hormone on the calcium current and isoparenaline-induced bacground current in rabbit ventricular myocytesJ Mol Cel CardiolYear: 199426925|
|Aras D,et al. Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidismInt J CardiolYear: 2005995915721500|
|Cacciatori V,et al. Power spectral analysis of heart rate in hyperthyroidismJ Clin Endocrinol MetabYear: 19968128288768838|
|Tukek T,et al. Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmalatrial fibrillationAm J CardiolYear: 20008589610758937|
|Katircibasi MT,et al. Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hypertyroidismExp Clin Endocrinol DiabetesYear: 200711537617701883|
|Nakazawa HK,et al. Management of atrial fi- brillation in the post-thyrotoxic stateAm J MedYear: 1982729037091161|
|Gunduz K,et al. The Relationship between P wave dispersion and diastolic dysfunctionTex Heart Inst JYear: 20053216316107107|
|Smit JW,et al. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled studyJ Clin Endocrinol MetabYear: 200590604116131580|
|Fazio S,et al. Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of blockadeJ Clin Endocrinol MetabYear: 19958022227608283|
|Biondi B,et al. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxineJ Clin Endocrinol MetabYear: 19968142248954019|
|Mercuro G,et al. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoringJ Clin Endocrinol MetabYear: 20008515910634380|
|Dilaveris PE,et al. P-wave duration and dispersion analysis: methodological considerationsCirculation Year: 2001103E11111382743|
Keywords: Hyperthyroidism, P wave dispersion, atrial fibrillation, propylthiouracil.
Previous Document: Use of a unique long pre-curved sheath to facilitate femoral placement of coronary sinus catheters.
Next Document: The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience ...